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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not in adult
patients with PC-BPPV, is the Semont Maneuver effective in reducing symptoms of vertigo?
STUDY DESIGN: Review of three published, randomized controlled trials (two double-blind
and one single blinded), all English language.
DATA SOURCES: The three randomized controlled trials that were used for this review were
found using PubMed and Medline. Articles were selected based on relevance and that the
outcomes were patient oriented.
OUTCOME(S) MEASURED: Dix-Hallpike Test performed before and after the Semont
Maneuver to asses nystagmus and questionnaires/self reported symptom status after the Semont
Maneuver to asses resolution of vertigo.
RESULTS: Mandala et al. and Chen et al. compared the Semont Maneuver to a Sham treatment.
Salvinelli et al. compared the Semont Maneuver to a no treatment group. All three studies
demonstrated statistically significant improvement in patient’s vertigo after receiving the Semont
Maneuver compared to other treatment strategies. Salvinelli et al. demonstrated that cure rates
with the Semont Maneuver (94.2%) were significantly higher and more effective than the no
treatment group (35.4%). Mandala et al. determined that at the 1 hr and 24 hr follow up, 79.3%
and 86.8% of subjects undergoing the Semont Maneuver recovered from vertigo, respectively.
Chen et al. concluded that on the fourth day, 84.62% of patients being treated with the Semont
Maneuver showed complete resolution of vertigo symptoms compared to 14.29% of patients
receiving Sham treatment.
CONCLUSIONS: The results of these three randomized controlled trials suggest that the Semont
Maneuver is a safe, easily performed, and effective treatment modality for patients with PCBPPV.
KEY WORDS: BPPV, Semont Maneuver
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INTRODUCTION
Benign Paroxysmal Positional Vertigo (BPPV) is a disorder of the inner ear that is caused
by free-floating calcium carbonate crystals (otoconia) that are displaced from the macula of the
utriculus and enter the semicircular canals. The posterior semicircular canal is most commonly
affected, occasionally the lateral semicircular canal, and rarely the anterior semicircular canal.
Movement of otoconia within the semicircular canals causes variations in the endolymphatic
pressure, which is manifested in a patient as vertigo and nystagmus. BPPV is the most common
form of positional vertigo and is the most common vestibular disease. 1 Its prevalence increases
with age but is often underestimated in older adults. In a study involving the geriatric population,
it was found that of the 77% of subjects that had a balance disorder, 9% had BPPV.2 It has been
estimated from physician data, laboratory data, and failed treatment costs that each patient with
BPPV spends $2009.63 in health care costs.3 In the United States, BPPV accounts for 18% of
visits to dizziness clinics each year.4
Being able to correctly diagnose BPPV and identify the cause is essential to the effective
treatment of the condition. The majority of cases of BPPV are idiopathic and are thought to be
triggered by a change in head position such as lying down, getting up, or rolling over in bed.
However, some of the identifiable causes of BPPV include Vestibular Neuronitis, Meniere
Disease, inner ear ischemia, trauma, surgery, and whiplash injuries. 5
The standard treatment for patients with BPPV is a particle-repositioning maneuver. The
most well-known and commonly used maneuvers include the Epley and Modified Epley
Maneuvers.6 Patients with BPPV are often educated to perform Brandt-Daroff exercises during
an attack in order to end the symptoms of vertigo, however these exercises are less effective in
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relieving symptoms than particle-repositioning maneuvers.7 Pharmacologic therapy is not useful
for brief episodes of vertigo associated with BPPV. However, vestibular suppressants may be
helpful in patients who have difficulty tolerating particle-repositioning maneuvers due to
discomfort and nausea. Betahistine is commonly given and rarely is Meclizine used.8
Currently, particle-repositioning remains the therapy of choice in the treatment of BPPV.
The Semont Maneuver is an additional particle-repositioning maneuver that may be used to
improve vertigo symptoms in patients with posterior canal BPPV (PC-BPPV).
OBJECTIVE
The objective of this selective EBM review is to determine whether or not in adult
patients with PC-BPPV, is the Semont Maneuver effective in reducing symptoms of vertigo.
METHODS
All three studies selected for this review focused on a population of adult (> 18 y/o)
patients with clinically diagnosed PC-BPPV. The intervention under investigation is the Semont
Maneuver versus the comparison groups of Sham treatment and no treatment. All three studies
measured improvement of vertigo symptoms subjectively by questionnaires/self reported
symptom status and objectively by patients’ response (nystagmus) to Dix-Hallpike testing. Two
of the studies chosen for this review were double-blinded randomized controlled trials and one of
the studies was a single-blinded randomized controlled trial.
The author completed a search using PubMed and Medline web databases using key
words “Benign Paroxysmal Positional Vertigo” and “Semont Maneuver.” All three articles were
published in English between 2004 and 2012 in peer-reviewed journals. The studies were
selected based on their relevance to the clinical question and focused on outcomes that were
patient oriented (POEMs).
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Inclusion criteria included studies that were randomized controlled trials published after
1999 that focused on patient oriented outcomes (POEMs). Subjects selected were adult (> 18
y/o) patients with diagnosed unilateral PC-BPPV via Dix-Hallpike Testing. Exclusion criteria
included patients < 18 y/o and patients with lateral or anterior semicircular canal BPPV.
Summary of statistics reported or used include P-values and mean change from baseline.
OUTCOMES MEASURED
The outcome measured in all three studies was improvement of vertigo symptoms. After
the Semont Maneuver was performed, the outcome was assessed subjectively by
questionnaires/self reported symptom status and objectively by patients’ response (nystagmus) to
Dix-Hallpike testing. Successful treatment was defined as a negative Dix-Hallpike test and
absence of vertigo.
RESULTS
All three studies were randomized controlled trials that evaluated the efficacy of the
Semont Maneuver compared to either Sham or no treatment groups. The clinical and
demographic baseline characteristics were not significantly different between the two groups
being compared in all three studies. Each study utilized dichotomous data with intention-to-treat
analysis. The relative benefit increase (RBI), absolute benefit increase (ABI), and numbers
needed to treat (NNT) were calculated using efficacy rates from the Semont Maneuver, Sham
treatment, and no treatment groups. These values were derived from experimental event rate
(EER) and controlled event rate (CER) using clinical success percentages defined as resolution
of vertigo. In each study, all patients completed the therapy and none were lost during the follow
up period.
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Table 1: Demographics & Characteristics of included studies
Study
Type # Pts Age (yrs)
Inclusion
Exclusion
Criteria
Criteria
Chen
RCT 128
Semont
- Pts with
- Pts with
(2012) 8
Group:
symptoms
bilateral PC53.55 yrs ±
of unilateral BPPV or
9.91 yrs
PC-BPPV
traumatic
Sham
and
BPPV.
Group:
diagnosed
- Pts with
52.35 yrs ±
via DixBPPV lasting
8.55 yrs
Hallpike
> 2 months
Test.
- Pts with
horizontal or
anterior canal
BPPV
Salvinelli RCT 156
Semont
- Pts with
- Pts with
9
(2004)
Group: mean diagnosed
asymmetrical
= 73 yrs
PC-BPPV
hearing loss
(range = 70- according to - Pts with
78 yrs)
Dixneurological
No Tx
Hallpike
diseases
Group: mean Test.
- Pts with
= 75 yrs
poor general
(range = 72health
79 yrs)
conditions
- Pts with an
abnormal BP
- Pts who
have used
Ototoxic
drugs
Mandala RCT 342
Semont
- Pts with
- Pts with
(2012) 10
Group: 62.1 diagnosed
bilateral PCyrs ± 15.1
unilateral
BPPV
yrs
PC-BPPV
- Pts with
Sham
according to multiple canal
Group: 63.9 Dixatypical
yrs ± 16.2
Hallpike
positional
yrs
Test.
nystagmus
- Pts
previously
treated with
repositioning
maneuvers

W/D

Interventions

0

- Semont
Maneuver

0

- Semont
Maneuver

0

- Semont
Maneuver
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In Mandala et al, a total of 342 adult (> 18 y/o) patients with diagnosed unilateral PCBPPV via Dix-Hallpike testing were recruited from 7 Otoneurology units in Italy. Excluded from
the study were patients with bilateral PC-BPPV, multiple canal atypical positional nystagmus, or
patients previously treated with repositioning maneuvers. Patients were randomized into a
treatment group by Semont Maneuver or Sham treatment. Sham treatment consisted of
performing the Semont Maneuver but for the unaffected ear. The Semont Maneuver and Sham
treatments were performed once and patients were assessed at 1 hr and 24 hrs. Patients in both
groups whose symptoms of BPPV hadn’t resolved at the 24 hr follow up were treated with the
Semont Maneuver. Patients were followed for 2 weeks and were instructed to return to the
hospital if BPPV symptoms persisted or reoccurred to be treated again with the Semont
Maneuver. 86.8 % of patients receiving the Semont Maneuver had complete resolution of
symptoms at 24 hrs post intervention compared to 0.00% in the Sham treatment group. When
comparing the two groups, the Semont Maneuver group was statistically more effective than the
Sham treatment group (P < 0.0001). The results are summarized in Table 2.
Table 2: Semont Maneuver vs Sham Treatment at 24 hrs.
% Cure
Rate

CER

EER

RBI

ABI

NNT

P-Value

0.00

0.868

1.00

0.868

2

< 0.0001

In Salvinelli et al, 156 adult (> 18 y/o) patients were selected after being diagnosed with
unilateral PC-BPPV via Dix-Hallpike testing. Subjects were enrolled at the Department of
Otolaryngology of Campus Bio Medico University in Rome, Italy. Patients excluded from the
study had a history of asymmetrical hearing loss, neurological disease, poor general health
conditions, abnormal blood pressure, and prior use of ototoxic drugs. Patients with BPPV were
randomized into either a Semont Maneuver group or no treatment group. Patients in the Semont
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Maneuver group were treated one to three times at 1-week intervals until resolution of their
symptoms. At the end of each treatment, a 6-month follow-up was performed. In the Semont
Maneuver group, 94.2% of patients had a resolution of symptoms after 3 sessions of Semont
Maneuver compared to only 34.6% in the no treatment group. When comparing the two groups,
the Semont Maneuver group was statistically more effective than the no treatment group (P <
0.001). The results are summarized in Table 3.
Table 3: Semont Maneuver vs No Treatment after 3 sessions.
% Cure
Rate

CER

EER

RBI

ABI

NNT

P-Value

0.346

0.942

1.72

0.596

2

< 0.001

In the Chen et al. study, 128 adult (> 18 y/o) patients with unilateral PC-BPPV were
enrolled from the neurology outpatient clinic at Changzheng Hospital. Patients were diagnosed
after having undergone bedside vestibular testing, including the Dix-Hallpike test, Rinne test,
Weber test, Romberg’s test, positional test, and a Fukuda test. Patients excluded from the study
had bilateral PC-BPPV, traumatic BPPV, BPPV lasting more than 2 months, or BPPV involving
the horizontal or anterior semicircular canals. Patients were randomized into a treatment group
by Semont Maneuver or a Sham treatment group. In the Semont Maneuver group, treatment was
repeated until resolution of symptoms or until 4 maneuvers had been performed. Sham treatment
consisted of a Semont Maneuver but for the unaffected side. Patients in both groups received
treatment with the Semont Maneuver if they hadn’t significantly improved by the fourth day. On
the fourth day after treatment, 84.62% of patients in the Semont Maneuver group were free of
symptoms compared to 14.29% in the Sham group. There was significant difference in the cure
rate between the two groups (P < 0.001). The results are summarized in Table 4.
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Table 4: Semont Maneuver vs Sham Treatment at day 4.
% Cure
Rate

CER

EER

RBI

ABI

NNT

P-Value

0.1429

0.8462

4.92

0.7033

2

< 0.001

DISCUSSION
This systematic review analyzed three randomized controlled trials to determine if the
Semont Maneuver is effective in the treatment of vertigo. Overall, the data demonstrates that the
Semont Maneuver is effective in resolving symptoms of vertigo in patients with PC-BPPV. All
three studies showed statistical significance.
In 1983, Alain Semont presented a new therapeutic technique for the treatment of PCBPPV known as the Semont Maneuver. It is an easily and quickly performed maneuver that can
be performed at a patient’s bedside as part of a clinician’s routine examination. In combination
with the Dix-Hallpike Test, patients with PC-BPPV can be diagnosed and treated at bedside
without the use of blood work or radiographic studies. Many practitioners recommend the use of
IR video goggles for monitoring eye movement during positioning, but this equipment is not
necessary to accurately diagnose and treat PC-BPPV.9 Thus, the Semont Maneuver is highly cost
effective and no special equipment is needed.9 It is recommended that every general practitioner
and geriatrician be able to use this maneuver to provide relief of patient’s symptoms.10
Currently there are no absolute contraindications to use this therapeutic treatment;
however, relative contraindications include any orthopedic condition that limits patient mobility
due to the brisk movement that occurs during the maneuver.10 When performing this maneuver,
there is a chance that free-floating particles may enter another canal, most commonly from the
posterior to the horizontal semicircular canal. This most likely occurs when the head is brought
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upright but not maintained in the proper position.9 Common minor side effects that may be
experienced include nausea, vomiting, loss of balance, pallor, and sweating.11
Various limitations existed in the three randomized clinical trials. In Salvinelli et al, the
study was only single blinded and thus the results may have been subject to bias by the unblinded investigator who performed the Dix-Hallpike testing both before and after the
intervention. In both Chen et al. and Salvinelli et al, patients were recruited from a single
Hospital whereas in Mandala et al patients were recruited from 7 Otoneurology units throughout
Italy. A larger demographic population may have helped increase the strength of the results. In
Mandala et al. and Chen et al, each study had short-term follow up periods of 2 weeks and a few
days respectively, which hinders the strength of their findings.
CONCLUSION
In conclusion, this systematic review of three randomized controlled trials demonstrates
that the Semont Maneuver is effective in the treatment of PC-BPPV. The data collected in all
three studies showed statistical significance in improving patient’s symptoms of vertigo. Particlerepositioning remains the therapy of choice for the treatment of PC-BPPV and this new body of
evidence suggests that the Semont Maneuver be strongly considered as a first line therapy in
patients with PC-BPPV. Further studies evaluating the relapse rates of the Semont Maneuver are
warranted. Lastly, a systematic review comparing the efficacy of the two most common particlerepositioning maneuvers, Epley and Semont, is warranted.
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